Finance

Lists
CVSH34:BVMF
Cvs Health Corporation BDR
50,65 R$
0,00%
(0,00) 1D
13 қар., 17:53:47 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for CVSH34...
Open
50,70 R$
High
50,70 R$
Low
50,26 R$
Mkt. cap
114,32 млрд
Avg. vol.
393,00
Volume
168,00
52-wk high
57,82 R$
52-wk low
36,22 R$
Shares outstanding
1,28 млрд
No. of employees
260 м.
Open
50,70 R$
High
50,70 R$
Low
50,26 R$
Mkt. cap
114,32 млрд
Avg. vol.
393,00
Volume
168,00
52-wk high
57,82 R$
52-wk low
36,22 R$
Shares outstanding
1,28 млрд
No. of employees
260 м.
News stories
From web sources and news partners
Profile
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores. On November 4, 2026, CVS announced that they will split into two companies, making it the largest split in the healthcare business. Wikipedia
About Cvs Health Corporation BDR
CEODavid Joyner
Employees260 м.
Founded1963
HeadquartersWoonsocket, Род-Айленд, Америка Құрама Штаттары
SectorHealth Care
IndustryHealth care provider
Last report
2026 ж. 04 қар.
Fiscal period
Q3 2026
2,09 $ / 1,65 $
+26,60%beat
Revenue / Est. (USD)
107,75 млрд / 104,69 млрд
+2,92%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
105,10 млрд
99,85 млрд
105,46 млрд
107,75 млрд
Cost of goods sold
92,13 млрд
84,80 млрд
90,35 млрд
93,50 млрд
Cost of revenue
92,13 млрд
84,80 млрд
90,35 млрд
93,50 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,32 млрд
10,93 млрд
11,04 млрд
11,32 млрд
Operating expense
11,32 млрд
10,93 млрд
11,04 млрд
11,32 млрд
Total operating expenses
103,45 млрд
95,73 млрд
101,38 млрд
104,82 млрд
Operating income
1,65 млрд
4,12 млрд
4,07 млрд
2,93 млрд
Other non operating income
-88,00 млн
32,00 млн
31,00 млн
30,00 млн
EBT including unusual items
1,35 млрд
3,94 млрд
3,98 млрд
2,85 млрд
EBT excluding unusual items
1,37 млрд
3,95 млрд
3,99 млрд
2,86 млрд
Income tax expense
-1,57 млрд
981,00 млн
982,00 млн
678,00 млн
Effective tax rate
-115,88%
24,91%
24,69%
23,80%
Other operating expenses
-
-
-
-
Net income
2,94 млрд
2,94 млрд
2,98 млрд
2,17 млрд
Net profit margin
2,80%
2,95%
2,82%
2,02%
Earnings per share
1,09
2,57
2,58
2,09
Interest and investment income
594,00 млн
574,00 млн
641,00 млн
647,00 млн
Interest expense
-787,00 млн
-774,00 млн
-757,00 млн
-747,00 млн
Net interest expenses
-193,00 млн
-200,00 млн
-116,00 млн
-100,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
2,80 млрд
5,23 млрд
5,20 млрд
4,06 млрд
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары